Search

OPIOID CRISIS THREATENS TO DRIVE MALLINCKRODT COMPANY TO BANKRUPTCY

... who are seeking compensation in an opioid scandal. The approximate amount of the organization's debt by the beginning of 2021 was $ 4.2 billion. We should remind our readers that Mallinckrodt is the main developer and manufacturer of broad spectrum drugs. Among the drugs produced by the company there are drugs for the treatment of autoimmune and many other diseases in the field of nephrology, pulmonology, ophthalmology, and rheumatology. However, Acthar Gel, one of the sales leaders, which brought ...

Sorted by relevance | Sort by date